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The Development ofa Metropolitan Regional Cytology Service Clinical cytological examination is concerned at present mainly with cancer, particularly cervical cancer. From correlation of cytological studies with careful histological evaluation of biopsies three groups of epithelial disorder have emerged: invasive carcinoma, carcinoma-in-situ and dysplasias. Large-scale use of smear examinations has revealed numerous examples of dysplasias in younger women. The view has developed that, over an unknown period of time, a series of changes may occur in cervical epithelium and that invasive carcinoma may result from the progression of dysplasia to carcinoma-in-situ to invasion. The logical assumption was that if early lesions could be discovered and excised locally, the incidence of invasive carcinoma would be reduced.
Many people believe that this hypothesis is not proven and that the expense is not justified. This paper attempts to answer the question: 'To what degree was there justification for the provision of such regionalized laboratory facilities as ours? ' A service was initially developed in 1965 for the consultant gynmcologists to whom problem cases would be referred, an expected figure being about 20 in every 1,000. Today, the laboratory deals with up to 4,000 cases per month from hospital, local health authorities, general practitioners and family planning clinics, as well as providing other cytodiagnostic facilities. It was desirable to acquire information which would shed light on the natural history of cervical cancer, and possibly also uterus and breast cancer. Careful record design and the development of a computerized retrieval and information system are making this feasible.
Various factors are beyond the control of the laboratory, such as the content and quality of the cervical smear. This consists of a heterogeneous collection of epithelial and mesenchymal cells in various stages of viability. The sample may not be easily repeatable and we regard the cell population as a mirror of physiological and pathological processes, the latter reflecting inflammation or neoplasia. In reporting, we use a modified Papanicolaou classification, whose primary purpose is to standardize communication within the laboratory, and we add any comment which may help in clinical management. We emphasize that our role is to aid diagnosis and not to act as a diagnostic slot machine. Some cytologists claim high diagnostic accuracy in predicting a tumour diagnosis from the cytological picture; we do this as an exercise only, and will only know with what accuracy when we review our material. We have tried to develop a policy of two smears within the first year, so as to reduce error, and a third within five years. A suitable analogy is that of a driver going through a series of traffic signals, say about ten in a lifetime. If the signals are green (Class I, II) all is well. There may be an amber (Class III) which can revert to green, but red (Class IV, V) means stop: 'Go and see a competent gynecologist'.
Our analysed data illustrate some of the variables. In June 1966, we participated in a tenday health screening exercise at Epsom. One consultant gynecologist analysed 1,200 cases examined by his team. He found that 1 woman in 7 had an erosion; 1 in 36 a cervicitis (cysts, scars or discharge); 1 in 25 a polyp; 1 in 57 fibroids; and 1 in 171 an ovarian or adnexal mass. This is a self-selected group, but the obvious question is, how to define a 'well woman' ? We have, therefore, included in our study any woman who comes primarily to get a cervical smear. Our analyses show good correlation between Class II smears and the presence of erosion, but poor correlation between abnornal smears and clinical assessment (Table 1) . Similar discrepancies exist in hospital cases, which we suggest further endorses the value of cervical smears in so-called asymptomatic women.
This past year I have analysed the histological records of the previous seven years of the St Helier and Croydon Groups to see what impact cytological examination is making. Fig 1 illustrates differences in attitudesone gyn=cologist will biopsy a cervix every time dilatation and curettage is performed; another is conservative. The former may pick up an occasional occult carcinoma but on the whole my impression is that the smear examination will replace the indiscriminate biopsy with no hazard to the patient.
Histological evaluation is considered the yardstick of cytological accuracy. The sampling and interpretation by the surgical pathologist may 1966 1967 19681969 1964 1965 1966 1967 1968 1969 YEAR I believe the science will justify itself although we still have to learn which lesions will progress, if regression truly does occur, and whether some of the dysplastic lesions may be but a response to inflammation. Thus, in the first 50,000 cases we have found 600 with cytological abnormality.
In general, Class IV or V smears prove to be insitu lesions or, rarely, invasive. Class m lesions are treated conservatively, about 20-30% proving to be borderline lesions. A special study of the significance of discharge in this group is being developed.
We, are seeing a fascinating change in tumour incidence: endometrial carcinoma, formerly less frequent than cervical carcinoma, is becoming more common. Accurate costing is not possible, and a crude figure for our reading a smear is £0-50. For the past three years, we have been field testing the Vickers Screening Apparatus. Costs will be cut considerably if we can satisfy ourselves that it fulfils its function of helping us sieve out abnormal smears. Under these circumstances, the cervical smear should play a similar role for the clinician as blood film examination must have done in the days when addisonian anemia was considered a fatal disease. The evidence suggests that the clinician cannot do without this test and that it obeys Sydenham's rule that 'what is useful is good'.
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Effects of Screening Programmes on Laboratory Organization
One of the main effects of screening programmes may well be that laboratories will have to develop an impersonal attitude towards the investigations sent to a centralized laboratory, and will lose the close and personal relationships which have now developed between pathologists and their clinical colleagues.
A new philosophy is required and it is not easy for any present-day laboratory organization to jump into screening without comprehending this philosophy. Most clinicians are brought up to accept a time-table of laboratory processing which is geared to speedy diagnosis, so that therapeutic adjustments may be quickly instituted. Emergency services which have to be maintained throughout 24 hours are also essential so that quick answers may be obtained at any hour of the day or night if they are justified.
In theory, screening programmes are certainly not urgent, yet there has to be some degree of urgency in the carrying out of the tests once they arrive in the laboratory. This is because the machines have to be kept going and the results churned out, or the whole system will get blocked with the large amount of material waiting to be processed.
Automation must not be confused with screening. Anybody undertaking screening will have to introduce automation; it could hardly be done without. But automation is already required and is almost essential in most laboratories for reasons already well describedability to deal with the greatly increasing volume of requests, the reduction of the cost per test, speed and accuracy due to better built-in quality control. Immediately automation is introduced, the potential of the laboratory will be greatly increased and a bottleneck occurs unless data processing is added. From this it is a small step to the demand for profile screening and, later perhaps, population screening. Automation itself usually means that 12 or 15 results can be supplied from one sample of blood. Then, as so many people have said, it is easier to do all 15 tests than to sort out one or two channels for special investigation. In fact, most systems are so inelastic that you have to have the whole output. Many laboratories are now geared to multi-channel biochemistry and hematology for their routine investigation of both inpatients and outpatients.
The effect on clinicians is bad, Every time a doctor asks for a blood urea he will get back 15 results, and he will soon be demanding indiscriminately all the 15 investigations. Even if 15 tests are needed for proffles they are certinly not necessary for repeat and up-dating of results.
Screening (Single Investigations)
Phenylketonuria: Most authorities have centralized this investigation into one laboratory in each region; material is sent there, special staff is engaged, special areas of the laboratory are designated, recording and statistical analysis are provided so that the whole picture in a region can be assessed. With an incidence of one positive per 15,000 tests, Professor Whitehead estimates that each positive finding costs about £1,000. This must be set against the cost to the community of institutional care for an undetected affected child for life. We are not very far from full amino-acid deficiency screening on the same lines. Vaginal cytology: The effect of this screening procedure is very variable. Dr Levene has described a regional service: however, most area laboratories have screening facilities for vaginal cytology, and much useful information has been obtained on the natural history of carcinoma of the cervix. Perhaps we shall feel the money has been well spent when carcinoma of the cervix shows some signs of a fall in incidence.
